A randomized, phase II trial of oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrence

被引：0

作者：

Thatcher R. Heumann

Marina Baretti

Elizabeth A. Sugar

Jennifer N. Durham

Sheila Linden

Tamara Y. Lopez-Vidal

James Leatherman

Leslie Cope

Anup Sharma

Colin D. Weekes

Peter J. O’Dwyer

Kim A. Reiss

Dulabh K. Monga

Nita Ahuja

Nilofer S. Azad

机构：

[1] The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Departments of Biostatistics and Epidemiology

[2] The Bloomberg School of Public Health at Johns Hopkins,Yale Cancer Center

[3] Yale University School of Medicine,Abramson Cancer Center

[4] Massachusetts General Hospital Cancer Center,Medical Oncology

[5] University of Pennsylvania,undefined

[6] Allegheny General Hospital,undefined

来源：

Clinical Epigenetics | 2022年 / 14卷

关键词：

Pancreatic cancer; Epigenetic therapy; Clinical trial; Hypomethylation; Azacitidine; Maintenance therapy;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[21] Phase II clinical trial using novel peptide cocktail vaccine as a postoperative adjuvant treatment for surgically resected pancreatic cancer patients [J].

Miyazawa, Motoki ;

Katsuda, Masahiro ;

Maguchi, Hiroyuki ;

Katanuma, Akio ;

Ishii, Hiroshi ;

Ozaka, Masato ;

Yamao, Kenji ;

Imaoka, Hiroshi ;

Kawai, Manabu ;

Hirono, Seiko ;

Okada, Ken-ichi ;

Yamaue, Hiroki .

INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (04) :973-982

[22] PHASE I/II TRIAL OF DEXVERAPAMIL, EPIRUBICIN, AND GRANULOCYTE-MACROPHAGE-COLONY STIMULATING FACTOR IN PATIENTS WITH ADVANCED PANCREATIC ADENOCARCINOMA [J].

KORNEK, G ;

RADERER, M ;

SCHENK, T ;

PIDLICH, J ;

SCHULZ, F ;

GLOBITS, S ;

TETZNER, C ;

SCHEITHAUER, W .

CANCER, 1995, 76 (08) :1356-1362

[23] A randomized phase II trial of nab-paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer [J].

Hu, Zishuo Ian ;

Bendell, Johanna C. ;

Bullock, Andrea ;

LoConte, Noelle K. ;

Hatoum, Hassan ;

Ritch, Paul ;

Hool, Hugo ;

Leach, Joseph W. ;

Sanchez, James ;

Sohal, Davendra P. S. ;

Strickler, John ;

Patel, Ravindranath ;

Wang-Gillam, Andrea ;

Firdaus, Irfan ;

Yu, Kenneth H. ;

Kapoun, Ann M. ;

Holmgren, Eric ;

Zhou, Lei ;

Dupont, Jakob ;

Picozzi, Vincent ;

Sahai, Vaibhav ;

O'Reilly, Eileen M. .

CANCER MEDICINE, 2019, 8 (11) :5148-5157

[24] A Phase II Multicenter Study of the Addition of Azacitidine to Reduced-Intensity Conditioning Allogeneic Transplant for High-Risk Myelodysplasia (and Older Patients with Acute Myeloid Leukemia): Results of CALGB 100801 (Alliance) [J].

Vij, Ravi ;

Le-Rademacher, Jennifer ;

Laumann, Kristina ;

Hars, Vera ;

Owzar, Kouros ;

Shore, Tsiporah ;

Vasu, Sumithira ;

Cashen, Amanda ;

Isola, Luis ;

Shea, Thomas ;

DeMagalhaes-Silverman, Margarida ;

Hurd, David ;

Meehan, Kenneth ;

Beardell, Frank ;

Devine, Steven .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (10) :1984-1992

[25] SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapy [J].

Davis, Elizabeth J. ;

Zhao, Lili ;

Lucas, David R. ;

Schuetze, Scott M. ;

Baker, Laurence H. ;

Zalupski, Mark M. ;

Thomas, Dafydd ;

Chugh, Rashmi .

BMC CANCER, 2016, 16

[26] Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question-Erlotinib plus Gemcitabine for Resected Cancer of the Pancreatic Head A Phase II Randomized Clinical Trial [J].

Abrams, Ross A. ;

Winter, Kathryn A. ;

Safran, Howard ;

Goodman, Karyn A. ;

Regine, William F. ;

Berger, Adam C. ;

Gillin, Michael T. ;

Philip, Philip A. ;

Lowy, Andrew M. ;

Wu, Abraham ;

DiPetrillo, Thomas A. ;

Corn, Benjamin W. ;

Seaward, Samantha A. ;

Haddock, Michael G. ;

Song, Suisui ;

Jiang, Yixing ;

Fisher, Barbara J. ;

Katz, Alan W. ;

Mehta, Sharmila ;

Willett, Christopher G. ;

Crane, Christopher H. .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (03) :173-179

[27] Randomized double-blinded, placebo-controlled phase II trial of simvastatin and gemcitabine in advanced pancreatic cancer patients [J].

Jung Yong Hong ;

Eun Mi Nam ;

Jeeyun Lee ;

Joon Oh Park ;

Sang-Cheol Lee ;

Seo-Young Song ;

Seong Ho Choi ;

Jin Seok Heo ;

Se Hoon Park ;

Ho Yeong Lim ;

Won Ki Kang ;

Young Suk Park .

Cancer Chemotherapy and Pharmacology, 2014, 73 :125-130

[28] Cationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer: a randomized controlled phase II trial [J].

Loehr, J. M. ;

Haas, S. L. ;

Bechstein, W. -O. ;

Bodoky, G. ;

Cwiertka, K. ;

Fischbach, W. ;

Foelsch, U. R. ;

Jaeger, D. ;

Osinsky, D. ;

Prausova, J. ;

Schmidt, W. E. ;

Lutz, M. P. .

ANNALS OF ONCOLOGY, 2012, 23 (05) :1214-1222

[29] Randomized double-blinded, placebo-controlled phase II trial of simvastatin and gemcitabine in advanced pancreatic cancer patients [J].

Hong, Jung Yong ;

Nam, Eun Mi ;

Lee, Jeeyun ;

Park, Joon Oh ;

Lee, Sang-Cheol ;

Song, Seo-Young ;

Choi, Seong Ho ;

Heo, Jin Seok ;

Park, Se Hoon ;

Lim, Ho Yeong ;

Kang, Won Ki ;

Park, Young Suk .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (01) :125-130

[30] Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial [J].

Ravandi, Farhad ;

Roboz, Gail J. ;

Wei, Andrew H. ;

Dohner, Hartmut ;

Pocock, Christopher ;

Selleslag, Dominik ;

Montesinos, Pau ;

Sayar, Hamid ;

Musso, Maurizio ;

Figuera-Alvarez, Angela ;

Safah, Hana ;

Tse, William ;

Sohn, Sang Kyun ;

Hiwase, Devendra ;

Chevassut, Timothy ;

Pierdomenico, Francesca ;

La Torre, Ignazia ;

Skikne, Barry ;

Bailey, Rochelle ;

Zhong, Jianhua ;

Beach, C. L. ;

Dombret, Herve .

JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)

← 1 2 3 4 5 →